Rain. 44.6   F New York
AI-Powered News Summarizer
Top Stories

Health secretary says US will have 40 million doses of Covid-19 vaccine available by end of December

November 18, 2020. Summarized by summa-bot.

The United States plans to have about 40 million doses of Covid-19 vaccine available to distribute by the end of the year, Health and Human Services Secretary Alex Azar said during a briefing on Wednesday.

The United States plans to have about 40 million doses of Covid-19 vaccine available to distribute by the end of the year, Health and Human Services Secretary Alex Azar said during a briefing on Wednesday.

The companies Pfizer and Moderna this week both announced that their vaccine candidates were about 95% effective in Phase 3 trials.

Millions of children have missed routine vaccinations during the Covid-19 pandemic, and that is putting the US at risk from diseases like measles, whooping cough and polio, according to new data from Blue Cross Blue Shield Association released Wednesday.

“The new BCBSA vaccine data, based on medical claims from millions of Blue Cross and Blue Shield (BCBS) members, provides clear evidence that the United States is at risk of widespread outbreaks of preventable disease,” the group said in a statement.

The German biotech company BioNTech is working on a formula for its vaccine that would allow it to be shipped at room temperature, CEO Uğur Şahin told CNN’s Frederik Pleitgen in an exclusive interview on Wednesday.

German pharmaceutical company BioNTech, which has been working on a Covid-19 vaccine with US Pharmaceutical giant Pfizer, will file paperwork for the emergency use of its vaccine in the United States on Friday, the company CEO, Uğur Şahin told CNN in an interview on Wednesday.

Earlier today, Pfizer announced that a final analysis of the Phase 3 trial of its coronavirus vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns.

Pfizer announced its Covid-19 vaccine was 95% effective in preventing infection, according to a final analysis of its Phase 3 trial.

"B cell memory to some other infections has been observed to be long-lived, including 60+ years after smallpox vaccination, or 90+ years after infection with influenza," the researchers wrote in their study.

While World Health Organization data today showed that Europe has recorded a 10% decline in Covid-19 cases over the past week "for the first time in over three months," deaths continued to increase.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.

Suggestions